| Literature DB >> 35495265 |
Yi Qiu1, Qi Guo1, Yan-Qin Ran2, Wen-Jian Lan3, Chi-Keung Lam1, Gong-Kan Feng4, Rong Deng4, Xiao-Feng Zhu4, Hou-Jin Li1, Liu-Ping Chen1.
Abstract
Eight different culture media were used to culture shellfish Panopea abbreviate associated fungus Aspergillus sp. XBB-4. In a glucose-peptone-yeast (GPY) culture medium supplied with amino acids, this fungus can produce chemodiversity metabolites. Four new alkaloids including three β-carboline alkaloids, aspercarbolines A-C (1-3) and one piperazinedione, asperdione A (13) along with nine known compounds were isolated. The structures were elucidated mainly based on the NMR, MS, ECD and X-ray single-crystal diffraction data. The possible biosynthetic pathways of aspercarbolines A-C (1-3) were proposed. All compounds (1-13) were evaluated for their cytotoxicity against six cancer cell lines, including human nasopharyngeal carcinoma cell lines CNE1, CNE2, HONE1 and SUNE1, and human hepatocellular carcinoma cell lines hepG2 and QGY7701. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35495265 PMCID: PMC9049147 DOI: 10.1039/c9ra10306f
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Chemical structures of compounds 1–13.
1H and 13C NMR data for 1–3 (δ in ppm)
| No. | 1 (in acetone-d6) | 2 (in CDCl3) | 3 (in DMSO-d6) | |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| 1 | 148.3, C | 135.6, C | 135.8, C | |||
| 3 | 138.0, CH | 8.28, d (5.0) | 138.4, CH | 8.54, d (4.8) | 137.3, CH | 8.49, d (4.8) |
| 4 | 114.2, CH | 7.98, d (5.0) | 119.5, CH | 8.17, d (4.8) | 119.2, CH | 8.41, d (4.8) |
| 5 | 122.2, CH | 8.21, d (8.0) | 122.0, CH | 8.15, d (8.0) | 121.7, CH | 8.29, d (8.0) |
| 6 | 120.3, CH | 7.25, dd (8.0, 1.0) | 121.0, CH | 7.34, dd (8.0, 1.2) | 120.1, CH | 7.29, dd (8.0, 1.2) |
| 7 | 128.9, CH | 7.54, dd (8.0, 1.0) | 129.5, CH | 7.60, dd (8.0, 1.2) | 128.8, CH | 7.58, dd (8.0, 1.2) |
| 8 | 113.0, CH | 7.71, d (8.0) | 112.1, CH | 7.57, d (8.0) | 113.0, CH | 7.80, d (8.0) |
| 9-NH | 10.63, s | 10.18, s | 11.90, s | |||
| 10 | 133.9, C | 135.3, C | 134.0, C | |||
| 11 | 129.9, C | 131.8, C | 130.9, C | |||
| 12 | 122.0, C | 120.8, C | 119.8, C | |||
| 13 | 141.7, C | 141.3, C | 141.8, C | |||
| 1′ | 73.3, CH | 5.37, dd (8.0, 4.0) | 202.8, C | 203.5, C | ||
| 2′ | 40.5, CH2 | 2.21, m; 2.11, m | 32.2, CH2 | 3.85, t (6.4) | 70.7, CH | 3.56, m |
| 3′ | 60.4, CH2 | 3.87, dt (10.5, 6.0); 3.80, dt (10.5, 6.0) | 32.3, CH2 | 2.89, t (6.4) | 28.0, CH2 | 1.96, m; 1.69, m |
| 4′ | 208.9, C | 33.6, CH2 | 3.42, m | |||
| 5′ | 68.5, CH2 | 4.47, s | 65.9, CH2 | 3.36, m | ||
| 1′-OH | 5.15, s | |||||
| 2′-OH | 4.55, d (5.2) | |||||
| 3′-OH | 4.03, s | |||||
| 5′-OH | 3.13, s | 4.50, t (5.6) | ||||
1H and 13C NMR data were recorded at 500/125 MHz, respectively.
1H and 13C NMR data were recorded at 400/100 MHz, respectively.
Fig. 21H–1H COSY (bold lines), main HMBC (blue arrows) correlations of compounds 1–3.
Fig. 3Experimental ECD spectrum in MeOH and the calculated ECD spectra of compound 1.
Fig. 4Experimental ECD spectrum in MeOH and the calculated ECD spectra of compound 3.
1H (600 MHz) and 13C NMR (150 MHz) data for 13 in CDCl3 (δ in ppm)
| No. |
|
|
|---|---|---|
| 1 | NH | 9.13, s |
| 2 | 160.2, C | |
| 3 | 132.4, C | |
| 4 | NH | 7.55, s |
| 5 | 166.1, C | |
| 6 | 51.9, CH | 4.26, q (7.2) |
| 7 | 105.4, CH | 6.93, s |
| 8 | 124.3, C | |
| 9 | N | |
| 10 | 132.5, CH | 6.02, brs |
| 11 | NH | 11.95, s |
| 12 | 136.8, C | |
| 13 | 37.8, C | |
| 14 | 144.8, CH | 6.04, dd (17.4, 10.8) |
| 15 | 113.6, CH2 | 5.20, d (17.4); 5.17, d (10.8) |
| 16 | 28.1, CH3 | 1.51, s |
| 17 | 28.1, CH3 | 1.51, s |
| 18 | 21.5, CH3 | 1.57, d (7.2) |
Fig. 61H–1H COSY (bold lines), main HMBC (blue arrows) correlations of compound 13.
Fig. 5Experimental ECD spectrum in MeOH and the calculated ECD spectra of compound 13.
Fig. 7ORTEP diagram for the single-crystal X-ray structure of compound 13.
Fig. 8Proposed biosynthetic pathway of compound 1.
Fig. 9Proposed biosynthetic pathways of compounds 2 and 3.
Cytotoxicities of compounds 1–13 against six cancer cell lines, IC50 (μM)a
| Compounds | CNE1 | CNE2 | HONE1 | SUNE1 | HepG2 | QGY7701 |
|---|---|---|---|---|---|---|
| 1 | 95.70 | — | 77.61 | 85.94 | — | — |
| 2 | — | — | 84.29 | 94.05 | — | — |
| 3 | 16.29 | 20.58 | 20.11 | 45.31 | 50.85 | 28.97 |
| 4 | 43.31 | 38.53 | 42.85 | 64.95 | 65.03 | 20.64 |
| 5 | 60.42 | 64.04 | 74.58 | 70.72 | — | 51.93 |
| 6 | 22.34 | 8.69 | 31.35 | 23.44 | 49.79 | 32.76 |
| 7 | — | — | — | — | 76.53 | 30.40 |
| 8 | — | — | — | — | — | — |
| 9 | — | — | 80.28 | — | — | 59.40 |
| 10 | 74.67 | — | 97.39 | — | 60.13 | 35.49 |
| 11 | 62.57 | — | 85.13 | — | — | 49.27 |
| 12 | 40.58 | — | 71.16 | — | 16.93 | 8.82 |
| 13 | 22.00 | 18.93 | 21.61 | 16.93 | 12.33 | 10.72 |
| Hirsutanol A | 10.08 | 12.72 | 17.40 | 3.50 | 10.11 | 21.12 |
“−” means “>100”.